Stifel upgrades biotech stock on a narrative shift in Alzheimer’s treatment
Stifel sees Biogen stock rallying nearly 32% from here.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Biogen
since
auto-detected in 5 stories
30 days ago
3 months ago
Stocks making the biggest moves midday: Frontier Group, Kraft Heinz, Biogen and more
These are the stocks posting the largest moves in midday trading.
Stocks making the biggest premarket moves: Kraft Heinz, PepsiCo, Biogen, Signet Jewelers and more
These are the stocks posting the largest moves in the premarket.
US regulator approves at-home Alzheimer’s drug from Eisai and Biogen
found
a story from Financial Times ✅ › Financial Times
Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales
9 months ago
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
page 1 of 1